← Back to search

BELLUS Sante inc.

BLU · NASDAQ

Pharmaceutical Preparation Manufacturing

BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The Company's product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus.

ESG Scores

Overall ESG
5.4
Environmental
6.4
Social
3.2
Governance
6.2

Gender Diversity

Female Directors0.125%